$JNJ Recent Headlines Feds, pharma rivals team u
Post# of 144480
Posted On: 02/07/2014 10:11:57 AM
$JNJ Recent Headlines
Feds, pharma rivals team up on Alzheimer's 2:32 p.m. Feb. 6, 2014 - blogs.marketwatch.com
CVS move won’t slow e-cigarette sales 4:42 p.m. Feb. 5, 2014 - Jonnelle Marte
Newscast: Stocks mixed to start short week 6:32 p.m. Jan. 21, 2014 - MarketWatch
U.S. stocks close higher; earnings misses drag on Dow 4:51 p.m. Jan. 21, 2014 - Anora Mahmudova
Newscast: Stocks open week mixed 4:32 p.m. Jan. 21, 2014 - MarketWatch
Nasdaq nabs 13-year high, but Dow slips: stock market live blog recap 4:05 p.m. Jan. 21, 2014 - blogs.marketwatch.com
Ken Fisher's new top stock picks 2:48 p.m. Jan. 21, 2014 - Insider Monkey
Johnson & Johnson shares take a hit on full-year outlook 11:27 a.m. Jan. 21, 2014 - blogs.marketwatch.com
Newscast: Demand soars for humanely-raised pork 10:00 a.m. Jan. 21, 2014 - MarketWatch
Johnson & Johnson’s profit jumps 37% 9:49 a.m. Jan. 21, 2014 - Tess Stynes
Stock futures rise after China’s cash injections 9:32 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson sees 2014 EPS of $5.75 to $5.85 7:51 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 EPS excluding items $1.24 7:50 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 sales up 4.5% to $18.4B 7:49 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 EPS $1.23 vs. 91 cents 7:48 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Verizon, Delta, IBM are stocks to watch Tuesday 6:28 a.m. Jan. 21, 2014 - Sue Chang
‘Sloppy’ market turns to consumer, tech earnings 8:00 a.m. Jan. 19, 2014 - Wallace Witkowski
Carlyle buying J&J diagnostics unit for $4.15 bln 8:17 a.m. Jan. 16, 2014 - William L. Watts
Carlyle offers $4.15 bln for J&J diagnostics unit 8:04 a.m. Jan. 16, 2014 - William L. Watts
Pharmacyclics shares soar after panel says cancer drug met goals 12:09 p.m. Jan. 7, 2014 - blogs.marketwatch.com
Carlyle to Buy Illinois Tool Unit for $3.2 Billion 7:07 p.m. Feb. 6, 2014 - WSJ.com
Johnson & Johnson (JNJ): Today's Featured Drugs Winner 5:00 p.m. Feb. 6, 2014 - TheStreet.com
Interesting JNJ Put And Call Options For March 14th 11:01 a.m. Feb. 6, 2014 - TheStreet.com
February High Yield Dividend Champion 5:34 a.m. Feb. 6, 2014 - Seeking Alpha
DXCM: Improving the Quality of Life for Children With Diabetes 8:38 p.m. Feb. 5, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: A Matter of Distrust 7:51 p.m. Feb. 5, 2014 - TheStreet.com
Pullback In Stock Prices Makes These Dividend Payers Attractive Again 6:51 p.m. Feb. 5, 2014 - Seeking Alpha
Stocks Tend to Outperform Bonds but with Greater Risk 5:08 p.m. Feb. 5, 2014 - GuruFocus.com
Smith & Nephew Becomes Pharma Family Factor 6:30 a.m. Feb. 5, 2014 - TheStreet.com
AstraZeneca's Prescription for Growth 6:00 a.m. Feb. 5, 2014 - TheStreet.com
Gilead Beats Q4 Estimates, But Ducks Sovaldi Guidance 5:51 p.m. Feb. 4, 2014 - Investors Business Daily
My First Equity Investment Since 2012 9:57 a.m. Feb. 4, 2014 - GuruFocus.com
Is Anyone Really Surprised By The Recent Stock Market Sell-Off?! 9:12 a.m. Feb. 4, 2014 - Seeking Alpha
Merrill Lynch’s Top Dividend and Yield Stocks to Buy During the Pullback 8:36 a.m. Feb. 4, 2014 - 247WallSt.com
Big Pharma firms, NIH to join up to study major diseases 8:28 a.m. Feb. 4, 2014 - Seeking Alpha
Today's Market: What We Are Buying And Looking To Buy On This Pullback 8:13 a.m. Feb. 4, 2014 - Seeking Alpha
Merck's Future Looks Healthier 6:00 a.m. Feb. 4, 2014 - TheStreet.com
2 Steps To A Solid And Profitable Portfolio 5:34 a.m. Feb. 4, 2014 - Seeking Alpha
Rival Companies, NIH Form Pact in Search for New Drugs 11:04 p.m. Feb. 3, 2014 - WSJ.com
Why I Am Buying Philip Morris International 8:16 a.m. Feb. 3, 2014 - GuruFocus.com
United Kingdom Orthopedic Devices Market Outlook to 2020 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 1:10 p.m. Feb. 5, 2014 - PR Newswire - PRF
Sustainable Brands® Community Continues to Lead With Brand Innovation Conference 9:00 a.m. Feb. 5, 2014 - BusinessWire - BZX
Girard Gibbs LLP Represents Children Allegedly Injured by Risperdal 7:40 p.m. Feb. 4, 2014 - BusinessWire - BZX
OxySure De-Leverages to Improve Shareholder Value and Prepares for an Uplisting 10:38 a.m. Feb. 3, 2014 - ACCESSWIRE
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India 9:58 a.m. Feb. 3, 2014 - PR Newswire - PRF
Johnson & Johnson Issues Dr. Paul Janssen Award for Biomedical Research Call for Nominations 9:00 a.m. Feb. 3, 2014 - PR Newswire - PRF
Johnson & Johnson Announces Clinical Trial Data Sharing Agreement With Yale School of Medicine 8:00 a.m. Jan. 30, 2014 - PR Newswire - PRF
Johnson & Johnson Announces Clinical Trial Data Sharing Agreement With Yale School of Medicine 12:01 a.m. Jan. 30, 2014 - PR Newswire - PRF
Risperdal Lawsuit News: Johnson & Johnson Wins Appeal of $257 Million Louisiana Risperdal Verdict, Bernstein Liebhard LLP Reports 11:21 a.m. Jan. 29, 2014 - PR Newswire - PRF
PowerVision Closes $20MM in Its Series D Financing 4:15 p.m. Jan. 28, 2014 - PR Newswire - PRF
Two-Year Data from INNOVATION Trial on INCRAFT® AAA Stent Graft System Continues to Demonstrate Safety and Performance in Treatment of Abdominal Aortic Aneurysms 9:00 a.m. Jan. 28, 2014 - BusinessWire - BZX
Acclarent Launches a Complete Balloon Sinuplasty System for Children who Suffer From Chronic Sinusitis 8:00 a.m. Jan. 23, 2014 - BusinessWire - BZX
DePuy ASR Lawsuit News: DePuy ASR Hip Recall Continues to Impact Johnson & Johnson Earnings, Bernstein Liebhard LLP Reports 11:28 a.m. Jan. 22, 2014 - PR Newswire - PRF
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
Janssen Announces New Group Targeting Unmet Global Health Needs 8:15 a.m. Jan. 22, 2014 - PR Newswire - PRF
Three-Year Clinical Outcomes from STROLL Trial Demonstrate Sustained Durability and Performance of S.M.A.R.T.® Stent for Treatment of Peripheral Artery Disease 5:56 p.m. Jan. 21, 2014 - BusinessWire - BZX
MD Anderson Announces Collaboration With Johnson & Johnson Innovation On Cancer Immunotherapy 12:38 p.m. Jan. 21, 2014 - PR Newswire - PRF
Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results: 7:45 a.m. Jan. 21, 2014 - PR Newswire - PRF
Fitch: JNJ's Diagnostics Divestiture Makes Strategic Sense 8:47 a.m. Jan. 17, 2014 - BusinessWire - BZX
Johnson & Johnson Announces Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics 7:45 a.m. Jan. 16, 2014 - PR Newswire - PRF
Feds, pharma rivals team up on Alzheimer's 2:32 p.m. Feb. 6, 2014 - blogs.marketwatch.com
CVS move won’t slow e-cigarette sales 4:42 p.m. Feb. 5, 2014 - Jonnelle Marte
Newscast: Stocks mixed to start short week 6:32 p.m. Jan. 21, 2014 - MarketWatch
U.S. stocks close higher; earnings misses drag on Dow 4:51 p.m. Jan. 21, 2014 - Anora Mahmudova
Newscast: Stocks open week mixed 4:32 p.m. Jan. 21, 2014 - MarketWatch
Nasdaq nabs 13-year high, but Dow slips: stock market live blog recap 4:05 p.m. Jan. 21, 2014 - blogs.marketwatch.com
Ken Fisher's new top stock picks 2:48 p.m. Jan. 21, 2014 - Insider Monkey
Johnson & Johnson shares take a hit on full-year outlook 11:27 a.m. Jan. 21, 2014 - blogs.marketwatch.com
Newscast: Demand soars for humanely-raised pork 10:00 a.m. Jan. 21, 2014 - MarketWatch
Johnson & Johnson’s profit jumps 37% 9:49 a.m. Jan. 21, 2014 - Tess Stynes
Stock futures rise after China’s cash injections 9:32 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson sees 2014 EPS of $5.75 to $5.85 7:51 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 EPS excluding items $1.24 7:50 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 sales up 4.5% to $18.4B 7:49 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 EPS $1.23 vs. 91 cents 7:48 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Verizon, Delta, IBM are stocks to watch Tuesday 6:28 a.m. Jan. 21, 2014 - Sue Chang
‘Sloppy’ market turns to consumer, tech earnings 8:00 a.m. Jan. 19, 2014 - Wallace Witkowski
Carlyle buying J&J diagnostics unit for $4.15 bln 8:17 a.m. Jan. 16, 2014 - William L. Watts
Carlyle offers $4.15 bln for J&J diagnostics unit 8:04 a.m. Jan. 16, 2014 - William L. Watts
Pharmacyclics shares soar after panel says cancer drug met goals 12:09 p.m. Jan. 7, 2014 - blogs.marketwatch.com
Carlyle to Buy Illinois Tool Unit for $3.2 Billion 7:07 p.m. Feb. 6, 2014 - WSJ.com
Johnson & Johnson (JNJ): Today's Featured Drugs Winner 5:00 p.m. Feb. 6, 2014 - TheStreet.com
Interesting JNJ Put And Call Options For March 14th 11:01 a.m. Feb. 6, 2014 - TheStreet.com
February High Yield Dividend Champion 5:34 a.m. Feb. 6, 2014 - Seeking Alpha
DXCM: Improving the Quality of Life for Children With Diabetes 8:38 p.m. Feb. 5, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: A Matter of Distrust 7:51 p.m. Feb. 5, 2014 - TheStreet.com
Pullback In Stock Prices Makes These Dividend Payers Attractive Again 6:51 p.m. Feb. 5, 2014 - Seeking Alpha
Stocks Tend to Outperform Bonds but with Greater Risk 5:08 p.m. Feb. 5, 2014 - GuruFocus.com
Smith & Nephew Becomes Pharma Family Factor 6:30 a.m. Feb. 5, 2014 - TheStreet.com
AstraZeneca's Prescription for Growth 6:00 a.m. Feb. 5, 2014 - TheStreet.com
Gilead Beats Q4 Estimates, But Ducks Sovaldi Guidance 5:51 p.m. Feb. 4, 2014 - Investors Business Daily
My First Equity Investment Since 2012 9:57 a.m. Feb. 4, 2014 - GuruFocus.com
Is Anyone Really Surprised By The Recent Stock Market Sell-Off?! 9:12 a.m. Feb. 4, 2014 - Seeking Alpha
Merrill Lynch’s Top Dividend and Yield Stocks to Buy During the Pullback 8:36 a.m. Feb. 4, 2014 - 247WallSt.com
Big Pharma firms, NIH to join up to study major diseases 8:28 a.m. Feb. 4, 2014 - Seeking Alpha
Today's Market: What We Are Buying And Looking To Buy On This Pullback 8:13 a.m. Feb. 4, 2014 - Seeking Alpha
Merck's Future Looks Healthier 6:00 a.m. Feb. 4, 2014 - TheStreet.com
2 Steps To A Solid And Profitable Portfolio 5:34 a.m. Feb. 4, 2014 - Seeking Alpha
Rival Companies, NIH Form Pact in Search for New Drugs 11:04 p.m. Feb. 3, 2014 - WSJ.com
Why I Am Buying Philip Morris International 8:16 a.m. Feb. 3, 2014 - GuruFocus.com
United Kingdom Orthopedic Devices Market Outlook to 2020 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 1:10 p.m. Feb. 5, 2014 - PR Newswire - PRF
Sustainable Brands® Community Continues to Lead With Brand Innovation Conference 9:00 a.m. Feb. 5, 2014 - BusinessWire - BZX
Girard Gibbs LLP Represents Children Allegedly Injured by Risperdal 7:40 p.m. Feb. 4, 2014 - BusinessWire - BZX
OxySure De-Leverages to Improve Shareholder Value and Prepares for an Uplisting 10:38 a.m. Feb. 3, 2014 - ACCESSWIRE
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India 9:58 a.m. Feb. 3, 2014 - PR Newswire - PRF
Johnson & Johnson Issues Dr. Paul Janssen Award for Biomedical Research Call for Nominations 9:00 a.m. Feb. 3, 2014 - PR Newswire - PRF
Johnson & Johnson Announces Clinical Trial Data Sharing Agreement With Yale School of Medicine 8:00 a.m. Jan. 30, 2014 - PR Newswire - PRF
Johnson & Johnson Announces Clinical Trial Data Sharing Agreement With Yale School of Medicine 12:01 a.m. Jan. 30, 2014 - PR Newswire - PRF
Risperdal Lawsuit News: Johnson & Johnson Wins Appeal of $257 Million Louisiana Risperdal Verdict, Bernstein Liebhard LLP Reports 11:21 a.m. Jan. 29, 2014 - PR Newswire - PRF
PowerVision Closes $20MM in Its Series D Financing 4:15 p.m. Jan. 28, 2014 - PR Newswire - PRF
Two-Year Data from INNOVATION Trial on INCRAFT® AAA Stent Graft System Continues to Demonstrate Safety and Performance in Treatment of Abdominal Aortic Aneurysms 9:00 a.m. Jan. 28, 2014 - BusinessWire - BZX
Acclarent Launches a Complete Balloon Sinuplasty System for Children who Suffer From Chronic Sinusitis 8:00 a.m. Jan. 23, 2014 - BusinessWire - BZX
DePuy ASR Lawsuit News: DePuy ASR Hip Recall Continues to Impact Johnson & Johnson Earnings, Bernstein Liebhard LLP Reports 11:28 a.m. Jan. 22, 2014 - PR Newswire - PRF
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
Janssen Announces New Group Targeting Unmet Global Health Needs 8:15 a.m. Jan. 22, 2014 - PR Newswire - PRF
Three-Year Clinical Outcomes from STROLL Trial Demonstrate Sustained Durability and Performance of S.M.A.R.T.® Stent for Treatment of Peripheral Artery Disease 5:56 p.m. Jan. 21, 2014 - BusinessWire - BZX
MD Anderson Announces Collaboration With Johnson & Johnson Innovation On Cancer Immunotherapy 12:38 p.m. Jan. 21, 2014 - PR Newswire - PRF
Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results: 7:45 a.m. Jan. 21, 2014 - PR Newswire - PRF
Fitch: JNJ's Diagnostics Divestiture Makes Strategic Sense 8:47 a.m. Jan. 17, 2014 - BusinessWire - BZX
Johnson & Johnson Announces Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics 7:45 a.m. Jan. 16, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼